Researchers compared 113 COVID-19 patients and 97 people with Hepatitis C to understand how vitamin D affects blood platelets—tiny cells that help form clots. They found that COVID-19 patients had much lower vitamin D levels and different platelet behavior compared to Hepatitis C patients. The study suggests that low vitamin D in COVID-19 might explain why some patients develop dangerous blood clots. This discovery could help doctors better understand and treat serious complications from COVID-19.
The Quick Take
- What they studied: How vitamin D levels affect blood platelet counts and activity in people with COVID-19 compared to people with Hepatitis C
- Who participated: 210 adults total: 113 with confirmed COVID-19 and 97 with chronic Hepatitis C infection. Participants were divided into groups based on whether they had enough vitamin D or not.
- Key finding: COVID-19 patients had significantly lower vitamin D levels, lower platelet counts, and more active platelets compared to Hepatitis C patients (p < 0.001, meaning this difference is very unlikely to be by chance)
- What it means for you: If you have COVID-19, maintaining healthy vitamin D levels may be important for preventing blood clots. However, this study shows a connection, not proof that vitamin D prevents clots. Talk to your doctor about vitamin D testing and supplementation if you’re concerned.
The Research Details
This was an observational comparative study, which means researchers watched and measured what naturally happened in two groups of patients rather than assigning them to different treatments. The researchers collected blood samples from 113 COVID-19 patients and 97 Hepatitis C patients and measured their vitamin D levels and platelet counts. They then split each group into two: those with enough vitamin D and those with vitamin D deficiency. They used statistical tests to compare the platelet measurements between groups.
The researchers used standard medical tests to measure vitamin D in the blood and examined platelet numbers and activity markers. This type of study is useful for finding patterns and connections between different health measurements, but it cannot prove that one thing directly causes another.
Understanding the connection between vitamin D and blood platelets is important because blood clots are a serious complication in some COVID-19 patients. If vitamin D plays a role in this process, doctors might be able to prevent or reduce these dangerous complications by ensuring patients have adequate vitamin D levels. This research helps explain why COVID-19 affects the blood differently than other viral infections.
This study has several strengths: it compared two different diseases to show the differences are specific to COVID-19, it used established medical tests to measure vitamin D and platelets, and it included a reasonable number of patients. However, the study was observational, meaning it can show connections but not prove cause-and-effect. The study was published in 2026, so it’s very recent research. The journal ‘Health Science Reports’ is a peer-reviewed publication, meaning other experts reviewed the work before publication.
What the Results Show
COVID-19 patients had much lower vitamin D levels compared to Hepatitis C patients—this difference was highly significant statistically (p < 0.001). When researchers looked at patients who were vitamin D deficient, those with COVID-19 showed more dramatic changes in platelet counts and inflammatory markers compared to deficient Hepatitis C patients.
COVID-19 patients overall had lower platelet counts and higher signs of platelet activation (meaning the platelets were more ‘active’ or ready to form clots). These changes were more pronounced in COVID-19 patients than in Hepatitis C patients, suggesting that the combination of low vitamin D and COVID-19 infection creates a particularly problematic situation for blood clotting.
The inflammatory response—the body’s reaction to infection—appeared to be more severe in COVID-19 patients with vitamin D deficiency. This inflammation is connected to the platelet changes observed, suggesting that vitamin D deficiency may amplify the inflammatory response that leads to blood clot problems.
The study found that the relationship between vitamin D deficiency and platelet changes was stronger in COVID-19 than in Hepatitis C, indicating that COVID-19 infection specifically interacts with vitamin D status in a unique way. The inflammatory markers measured were consistently higher in vitamin D-deficient COVID-19 patients, suggesting that vitamin D may help regulate the immune response to COVID-19.
Previous research has shown that vitamin D plays a role in immune function and inflammation control. This study adds to that knowledge by showing a specific connection between vitamin D deficiency and blood clotting problems in COVID-19. The findings align with other research suggesting that COVID-19 causes more severe blood clotting issues than other viral infections, and now we have evidence that vitamin D deficiency may be part of the explanation.
This study shows a connection between vitamin D levels and platelet changes, but it cannot prove that low vitamin D causes the platelet problems—other factors could be involved. The study was observational, so researchers couldn’t control all the variables that might affect results. We don’t know if the patients’ vitamin D levels were low before infection or became low because of the infection. The study didn’t follow patients over time to see if vitamin D supplementation actually prevented blood clots. Additionally, we don’t know about other factors that might affect results, such as patients’ diets, sun exposure, or other medications they were taking.
The Bottom Line
Based on this research, maintaining adequate vitamin D levels appears important for COVID-19 patients, particularly regarding blood clotting risk. However, this is preliminary evidence suggesting a connection, not proof of benefit. If you have COVID-19 or are recovering from it, discuss vitamin D testing and supplementation with your doctor. General vitamin D recommendations (600-800 IU daily for most adults, higher for some groups) remain appropriate. Confidence level: Moderate—this study suggests vitamin D matters, but more research is needed to confirm optimal levels and supplementation strategies.
This research is most relevant to COVID-19 patients, especially those at high risk for blood clots or those with severe illness. People with Hepatitis C may also benefit from vitamin D monitoring, though the connection appears less critical. Healthcare providers treating COVID-19 patients should consider vitamin D status as part of comprehensive care. This research is less directly applicable to people without these infections, though maintaining adequate vitamin D is important for general health.
If vitamin D deficiency is contributing to blood clot risk, correcting it would likely take several weeks to months to show full effects, as vitamin D builds up in the body gradually. Blood platelet changes might begin improving within days to weeks of adequate vitamin D levels, but the full anti-inflammatory benefits could take longer. Don’t expect immediate results from vitamin D supplementation.
Want to Apply This Research?
- Track vitamin D supplementation intake (daily dose and type) alongside platelet-related symptoms like unusual bruising, bleeding, or clotting concerns. If you’ve had COVID-19, note your vitamin D level from blood tests and any changes in energy, inflammation markers, or recovery progress.
- If recommended by your doctor, establish a daily vitamin D supplementation routine at the same time each day. Set reminders to take supplements consistently. Log your vitamin D intake in the app and note any changes in how you feel, particularly regarding energy levels and recovery from illness.
- Request vitamin D level testing from your doctor every 3-6 months if you’ve had COVID-19 or are at risk for deficiency. Track trends over time in the app. Monitor for symptoms of blood clotting problems (unusual bruising, swelling, pain) and report these to your healthcare provider immediately. Keep records of supplementation and any dietary sources of vitamin D to correlate with blood test results.
This research shows a connection between vitamin D deficiency and blood platelet changes in COVID-19 patients, but does not prove that vitamin D deficiency directly causes blood clots. This information is for educational purposes and should not replace professional medical advice. If you have COVID-19, are recovering from COVID-19, or are concerned about blood clotting risk, consult your healthcare provider before starting any vitamin D supplementation or making changes to your treatment plan. Do not use this information to self-diagnose or self-treat. Blood clotting complications are serious medical emergencies—seek immediate medical attention if you experience signs of blood clots such as chest pain, shortness of breath, leg swelling, or severe pain.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.